E. Stenehjem

发表

Research needs in antibiotic stewardship

Jessina C. McGregor, P. Tamma, S. Fridkin, 2019, Infection Control & Hospital Epidemiology.

Multidrug-Resistant Bacteria: The Emerging Crisis

R. Gaynes, D. Livorsi, E. Stenehjem, 2013 .

Impact of Outpatient vs Inpatient ABSSSI Treatment on Outcomes: A Retrospective Observational Analysis of Medical Charts Across US Emergency Departments

T. Jenkins, S. Doron, Jack Brown, 2018, Open forum infectious diseases.

Use of Computer Decision Support in an Antimicrobial Stewardship Program (ASP)

J. Lloyd, E. Thorell, W. Buckel, 2015, Applied Clinical Informatics.

Broad‐ versus Narrow‐Spectrum Oral Antibiotic Transition and Outcomes in Health Care‐associated Pneumonia

N. Dean, W. Buckel, E. Stenehjem, 2016, Annals of the American Thoracic Society.

Antibiotic Use in Small Community Hospitals.

Xiaoming Sheng, Tom Greene, J. Lloyd, 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Antibiotic Stewardship in Small Hospitals: Barriers and Potential Solutions.

A. Srinivasan, E. Septimus, David Y. Hyun, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Reply to Buetti et al.

A. Hersh, A. Pavia, E. Stenehjem, 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

205Antimicrobial Stewardship Knowledge, Attitudes and Practices among Healthcare Professionals in Utah

A. Hersh, A. Owen-Smith, A. Pavia, 2014, Open Forum Infectious Diseases.

Infection Control Knowledge, Attitudes, and Practices among Healthcare Workers in Addis Ababa, Ethiopia

A. Tenna, R. Kempker, H. Blumberg, 2013, Infection Control & Hospital Epidemiology.

Antimicrobial Stewardship in Community Hospitals.

J. Veillette, W. Buckel, E. Stenehjem, 2018, The Medical clinics of North America.

Stewardship in Community Hospitals – Optimizing Outcomes and Resources (SCORE): A Cluster-Randomized Controlled Trial Investigating the Impact of Antibiotic Stewardship in 15 Small, Community Hospitals

R. Srivastava, J. Lloyd, J. Burke, 2016 .

Virulence factors of gram-negative bacteria in sepsis with a focus on Neisseria meningitidis.

D. Stephens, D. Livorsi, E. Stenehjem, 2011, Contributions to microbiology.

Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, MMWR. Morbidity and mortality weekly report.

Perspectives of Physician and Pharmacist Stewards on Successful Antibiotic Stewardship Program Implementation: A Qualitative Study

Jorie M. Butler, L. Damschroder, M. Samore, 2020, Open forum infectious diseases.

Survey of physician and pharmacist steward perceptions of their antibiotic stewardship programs

Jorie M. Butler, L. Damschroder, M. Samore, 2021, Antimicrobial Stewardship & Healthcare Epidemiology.

Antibiotic Prescribing in Urgent Care: Implementing Evidence-Based Medicine in a Rapidly Emerging Health Care Delivery Setting

R. Srivastava, T. Allen, A. Hersh, 2020, Quality management in health care.

Interim Estimates of COVID-19 Vaccine Effectiveness Against COVID-19–Associated Emergency Department or Urgent Care Clinic Encounters and Hospitalizations Among Adults During SARS-CoV-2 B.1.617.2 (Delta) Variant Predominance — Nine States, June–August 2021

K. Natarajan, S. Grannis, A. Naleway, 2021, MMWR. Morbidity and mortality weekly report.

Antibiotic Prescribing Variability in a Large Urgent Care Network: A New Target for Outpatient Stewardship.

M. Samore, A. Hersh, K. Brunisholz, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Small but Significantly Greater Incidence of Inflammatory Heart Disease Identified After Vaccination for Severe Acute Respiratory Syndrome Coronavirus 2

B. Horne, H. May, J. Muhlestein, 2021, Open forum infectious diseases.

A small but significantly greater incidence of inflammatory heart disease identified after vaccination for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)

B. Horne, H. May, K. Knowlton, 2021 .

Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19-Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity - Nine States, January-September 2021.

William F. Fadel, S. E. Reese, C. Mcevoy, 2021, MMWR. Morbidity and mortality weekly report.

Association between vitamin D deficiency and methicillin-resistant Staphylococcus aureus infection

C. Rentsch, A. Hidrón, D. Rimland, 2015, Infection.

Waning 2-Dose and 3-Dose Effectiveness of mRNA Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance — VISION Network, 10 States, August 2021–January 2022

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, MMWR. Morbidity and mortality weekly report.

MRSA nasal colonization burden and risk of MRSA infection.

D. Rimland, E. Stenehjem, 2013, American journal of infection control.

Trends in Multidrug-Resistant Bacteria and Clostridium difficile in an Integrated Healthcare Network, 2008–2015

J. Burke, E. Stenehjem, R. Mehta, 2016 .

Estimation of COVID-19 mRNA Vaccine Effectiveness Against Medically Attended COVID-19 in Pregnancy During Periods of Delta and Omicron Variant Predominance in the United States

William F. Fadel, M. Stockwell, R. Link-Gelles, 2022, JAMA network open.

Rapid streptococcal pharyngitis testing and antibiotic prescribing before and during the coronavirus disease 2019 (COVID-19) pandemic

Daniel J. Shapiro, A. Hersh, E. Stenehjem, 2022, Antimicrobial Stewardship & Healthcare Epidemiology.

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States, December 2021–June 2022

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, MMWR. Morbidity and mortality weekly report.

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022

S. E. Reese, C. Mcevoy, R. Link-Gelles, 2022, MMWR. Morbidity and mortality weekly report.

Policy statement from the Society for Healthcare Epidemiology of America (SHEA): Only medical contraindications should be accepted as a reason for not receiving all routine immunizations as recommended by the Centers for Disease Control and Prevention

David J Weber, W. Schaffner, T. Talbot, 2020, Infection Control & Hospital Epidemiology.

Central nervous system device infections.

W. Armstrong, E. Stenehjem, 2012, Infectious disease clinics of North America.

RE: Antibiotic Prescribing During Pediatric Direct-to-Consumer Telemedicine Visits

A. Hersh, E. Stenehjem, W. Daines, 2019, Pediatrics.

Clinical criteria for COVID-19-associated hyperinflammatory syndrome: a cohort study

Samuel M. Brown, R. Srivastava, Gregory L. Snow, 2020, The Lancet Rheumatology.

A Novel Program to Provide Drug Recovery Assistance and Outpatient Parenteral Antibiotic Therapy in People Who Inject Drugs

E. Stenehjem, S. Gelman, B. Webb, 2021, Open forum infectious diseases.

Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–17 Years — VISION Network, 10 States, April 2021–January 2022

William F. Fadel, S. E. Reese, M. Stockwell, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of Homologous and Heterologous COVID-19 Booster Doses Following 1 Ad.26.COV2.S (Janssen [Johnson & Johnson]) Vaccine Dose Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults — VISION Network, 10 States, December 2021–March 2022

William F. Fadel, C. Mcevoy, M. Stockwell, 2022, MMWR. Morbidity and mortality weekly report.

Effectiveness of a multimodal hand hygiene campaign and obstacles to success in Addis Ababa, Ethiopia

A. Tenna, R. Kempker, H. Blumberg, 2014, Antimicrobial Resistance and Infection Control.

Interventions to optimize antimicrobial stewardship

R. Foster, W. Buckel, E. Stenehjem, 2021, Antimicrobial Stewardship & Healthcare Epidemiology.

Antimicrobial Stewardship Knowledge, Attitudes, and Practices among Health Care Professionals at Small Community Hospitals

A. Hersh, A. Owen-Smith, A. Pavia, 2016 .

Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings

William F. Fadel, S. Schrag, K. Natarajan, 2021, The New England journal of medicine.

Antibiotic Exposure and Risk for Hospital-Associated Clostridioides difficile Infection

Jeffrey P. Ferraro, Samuel M. Brown, A. Subramanian, 2020, Antimicrobial Agents and Chemotherapy.

Cepheid Xpert MRSA Cycle Threshold in Discordant Colonization Results and as a Quantitative Measure of Nasal Colonization Burden

R. Gaynes, D. Rimland, S. Satola, 2012, Journal of Clinical Microbiology.

Burden Quantitative Measure of Nasal Colonization Discordant Colonization Results and as a Cepheid Xpert MRSA Cycle Threshold in

R. Gaynes, D. Rimland, C. Stafford, 2012 .

Urgent-care antibiotic prescribing: An exploratory analysis to evaluate health inequities

A. Hersh, L. Hicks, S. Kabbani, 2022, Antimicrobial Stewardship & Healthcare Epidemiology.

Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults — Nine States, January–September 2021

William F. Fadel, Sarah E. Reese, C. Mcevoy, 2021, MMWR. Morbidity and mortality weekly report.

Opportunities and challenges in improving antimicrobial use during the era of telehealth expansion: A narrative review

D. Livorsi, E. Stenehjem, Hiroyuki Suzuki, 2021, Antimicrobial Stewardship & Healthcare Epidemiology.

Adapting Antibiotic Stewardship to the Community Hospital.

H. Reisinger, D. Livorsi, E. Stenehjem, 2019, JAMA network open.

Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.

N. Dean, E. Stenehjem, K. Dascomb, 2015, Respiratory medicine.

Waning of vaccine effectiveness against moderate and severe covid-19 among adults in the US from the VISION network: test negative, case-control study

William F. Fadel, S. E. Reese, C. Mcevoy, 2022, BMJ.

Effectiveness of two-dose vaccination with mRNA COVID-19 vaccines against COVID-19–associated hospitalizations among immunocompromised adults—Nine States, January–September 2021

S. E. Reese, C. Mcevoy, S. Schrag, 2021, American Journal of Transplantation.

Protection of 2 and 3 mRNA Vaccine Doses Against Severe Outcomes Among Adults Hospitalized with COVID-19 - VISION Network, August 2021 - March 2022.

S. E. Reese, C. Mcevoy, P. Embí, 2022, The Journal of infectious diseases.

Longitudinal Evaluation of Clinical and Colonization Methicillin-Resistant Staphylococcus aureus Isolates Among Veterans

D. Rimland, M. Farley, S. Satola, 2015, Infection Control & Hospital Epidemiology.

Reduction of Methicillin-Resistant Staphylococcus aureus Infection among Veterans in Atlanta

D. Rimland, C. Stafford, E. Stenehjem, 2013, Infection Control & Hospital Epidemiology.

Sex-specific differences in treatment outcomes for patients with HIV and AIDS

J. Shlay, E. Stenehjem, 2008, Expert review of pharmacoeconomics & outcomes research.

Streptococcus Intermedius: A Mimicker of Brain Metastases and A Potential Pitfall for Radiation Oncologists

E. Stenehjem, J. Evans, D. Gill, 2021, Advances in radiation oncology.

Estimation of COVID-19 mRNA Vaccine Effectiveness and COVID-19 Illness and Severity by Vaccination Status During Omicron BA.4 and BA.5 Sublineage Periods

William F. Fadel, S. E. Reese, C. Mcevoy, 2023, JAMA network open.

Improving tuberculosis screening and isoniazid preventive therapy in an HIV clinic in Addis Ababa, Ethiopia.

A. Tenna, R. Kempker, H. Blumberg, 2013, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Impact of Implementing Antibiotic Stewardship Programs in 15 Small Hospitals: A Cluster-Randomized Intervention

R. Srivastava, J. Burke, T. Greene, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

A Fully Integrated Infectious Diseases and Antimicrobial Stewardship Telehealth Service Improves Staphylococcus aureus Bacteremia Bundle Adherence and Outcomes in 16 Small Community Hospitals

Joseph D Dalto, Jordan Albritton, J. Veillette, 2022, Open forum infectious diseases.

Sustained Reduction in Urgent Care Antibiotic Prescribing During the Coronavirus Disease 2019 Pandemic: An Academic Medical Center’s Experience

David R Ha, M. Holubar, Lina Meng, 2022, Open forum infectious diseases.

Real-world Effectiveness and Tolerability of Monoclonal Antibody Therapy for Ambulatory Patients With Early COVID-19

Samuel M. Brown, W. Buckel, J. Bledsoe, 2021, Open forum infectious diseases.

Real-World Effectiveness and Tolerability of Monoclonal Antibodies for Ambulatory Patients with Early COVID-19

M. Shah, W. Buckel, J. Bledsoe, 2021, medRxiv.

Effectiveness of COVID-19 Vaccines at Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompromised Adults: An Observational Study of Real-World Data Across 10 US States from August-December 2021

S. E. Reese, C. Mcevoy, P. Embí, 2022, medRxiv.